CN1169825C - 从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 - Google Patents
从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 Download PDFInfo
- Publication number
- CN1169825C CN1169825C CNB021098255A CN02109825A CN1169825C CN 1169825 C CN1169825 C CN 1169825C CN B021098255 A CNB021098255 A CN B021098255A CN 02109825 A CN02109825 A CN 02109825A CN 1169825 C CN1169825 C CN 1169825C
- Authority
- CN
- China
- Prior art keywords
- honey locust
- acid
- triterpenic acid
- chinese honey
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title claims abstract description 76
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 18
- 241000931143 Gleditsia sinensis Species 0.000 claims abstract description 80
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 20
- 238000000605 extraction Methods 0.000 claims abstract description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 8
- 239000008367 deionised water Substances 0.000 claims abstract description 6
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 6
- 239000011347 resin Substances 0.000 claims abstract description 4
- 229920005989 resin Polymers 0.000 claims abstract description 4
- 208000004930 Fatty Liver Diseases 0.000 claims abstract description 3
- 206010019708 Hepatic steatosis Diseases 0.000 claims abstract description 3
- 230000000274 adsorptive effect Effects 0.000 claims abstract description 3
- 238000010828 elution Methods 0.000 claims abstract description 3
- 208000010706 fatty liver disease Diseases 0.000 claims abstract description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 claims abstract description 3
- 150000008130 triterpenoid saponins Chemical class 0.000 claims abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 229930182493 triterpene saponin Natural products 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 239000003981 vehicle Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229940124531 pharmaceutical excipient Drugs 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 7
- 239000000284 extract Substances 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 238000004042 decolorization Methods 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 32
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 229960003512 nicotinic acid Drugs 0.000 description 10
- 235000001968 nicotinic acid Nutrition 0.000 description 10
- 239000011664 nicotinic acid Substances 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000009465 diaoxinxuekang Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960002662 propylthiouracil Drugs 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- -1 thinner Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 230000001906 cholesterol absorption Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021098255A CN1169825C (zh) | 2002-05-22 | 2002-05-22 | 从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021098255A CN1169825C (zh) | 2002-05-22 | 2002-05-22 | 从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1386744A CN1386744A (zh) | 2002-12-25 |
CN1169825C true CN1169825C (zh) | 2004-10-06 |
Family
ID=4740807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021098255A Expired - Lifetime CN1169825C (zh) | 2002-05-22 | 2002-05-22 | 从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1169825C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100395258C (zh) * | 2003-03-28 | 2008-06-18 | 中国医学科学院药用植物研究所 | 枇杷叶总三萜酸组分及其在制备抗炎、止咳药物中的应用 |
CN103145790B (zh) * | 2013-03-18 | 2015-02-11 | 山东省中医药研究院 | 从猪牙皂中同时制备齐墩果酸和刺囊酸的方法 |
CN105111180A (zh) * | 2015-07-21 | 2015-12-02 | 河南科技大学 | 从低醇皂刺中提取新环烯醚萜化合物和其他化合物的方法 |
CN112007417A (zh) * | 2020-08-20 | 2020-12-01 | 赣州禾绿康健生物技术有限公司 | 一种灵芝三萜提取物中多菌灵的脱除装置及方法 |
CN117843280B (zh) * | 2023-11-28 | 2024-06-28 | 四川交通职业技术学院 | 一种混凝土早强剂及其制备方法 |
-
2002
- 2002-05-22 CN CNB021098255A patent/CN1169825C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1386744A (zh) | 2002-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1228344C (zh) | 薯蓣皂苷的制备方法、药物制剂及其医药新用途 | |
CN1733766A (zh) | 具有镇咳祛痰活性的岩白菜素类化合物及其药物组合物 | |
CN1724529A (zh) | 高纯度蛇床子素及其制备方法和以该化合物为活性成分的药物组合物 | |
CN1169825C (zh) | 从皂角中提取皂角三萜酸的方法及皂角三萜酸的医药用途和中药制剂 | |
CN1733054A (zh) | 一种山茱萸提取物及其制备工艺 | |
CN1384090A (zh) | 丹参总酚酸的提取方法及其制剂的制法与用途 | |
CN1186051C (zh) | 一种化痰止咳的药物及其生产方法 | |
CN1316960C (zh) | 复方蛤青滴丸及其制备方法 | |
CN1544429A (zh) | 蜂胶黄酮提取物的制备方法、药物制剂及医药新用途 | |
CN1817351A (zh) | 苦碟子药用提取物的制备方法及其药物制剂 | |
CN100345534C (zh) | 一种茵栀黄软胶囊及其制备方法和用途 | |
CN1698822A (zh) | 一种治疗肝炎的肝苏滴丸及其制备方法 | |
CN1301100C (zh) | 胆木滴丸及其制备方法 | |
CN1660364A (zh) | 一种用于清热解毒的莲芝消炎滴丸及其制备方法 | |
CN1301099C (zh) | 地龙滴丸及其制备方法 | |
CN1768751A (zh) | 酚麻美愈分散片的制备方法 | |
CN1723030A (zh) | 包含进行了处理的花生种皮产品的用于治疗或预防过敏性疾病的物质 | |
CN1297254C (zh) | 熊胆川贝滴丸及其制备方法 | |
CN1431011A (zh) | 用于治疗肝炎的口服药物 | |
CN1682821A (zh) | 复方半边莲滴丸及其制备方法 | |
CN1307983C (zh) | 一种治疗高脂蛋白血症的脉安滴丸及其制备方法 | |
CN1493295A (zh) | 齐墩果酸滴丸及其制备方法 | |
CN1301107C (zh) | 以穿心莲内酯磺化物制备而成的滴丸及其制备方法 | |
CN1709413A (zh) | 一种用于舒肝利胆的金黄利胆滴丸及其制备方法 | |
CN1686382A (zh) | 一种咽喉清喉滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO Free format text: FORMER OWNER: TIANYAO SCIENCE AND TECHNOLOGY CO LTD, JILIN Effective date: 20060421 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060421 Address after: 130012 No. 36 Shu West Road, Chengdu, Sichuan, Jinniu District Patentee after: Chengdu Kanghong Sci-Tech Industry (Group) Co., Ltd. Address before: 130012 No. 509 Mao Xiang street, hi tech Industrial Development Zone, Jilin, Changchun Patentee before: Tianyao Science and Technology Co., Ltd., Jilin |
|
ASS | Succession or assignment of patent right |
Owner name: CHENGDU KANGHONG MEDICINE GROUP CO.LTD. Free format text: FORMER OWNER: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO., LTD. Effective date: 20081031 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081031 Address after: No 36, Shu West Road, Chengdu, Sichuan, Jinniu District Patentee after: Chengdu Kanghong Pharmaceuticals Group Co., Ltd. Address before: No 36, Shu West Road, Chengdu, Sichuan, Jinniu District Patentee before: Chengdu Kanghong Sci-Tech Industry (Group) Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210226 Address after: 611930 No.89 Hualong Road, Tianpeng Town, Pengzhou City, Chengdu City, Sichuan Province Patentee after: Sichuan Jishengtang Pharmaceutical Co.,Ltd. Address before: 610036 No. 36 Shu West Road, Chengdu, Sichuan, Jinniu District Patentee before: CHENGDU KANGHONG PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20041006 |
|
CX01 | Expiry of patent term |